Drug intelligence / Profile preview

Precivit-E

Development stage: Unknown
Lead developer: Precia Pharma
Modality: Small Molecules
Administration: Oral

Overview

Precivit-E is a branded generic oral vitamin supplement developed and marketed by Precia Pharma, an Indian pharmaceutical company focused on lifestyle disease management. The product contains Vitamin E (typically as alpha-tocopherol), a fat-soluble nutrient that serves as a critical antioxidant within the body. It functions by scavenging reactive oxygen species (ROS) and protecting polyunsaturated fatty acids in cell membranes from lipid peroxidation. Precivit-E is indicated for general nutrient supplementation and is often used to support patients with conditions where oxidative stress plays a significant role, such as diabetes, neuropathy, and cardiovascular diseases.

Brand names: Precivit-E
Other names: vitamin E

Beyond the preview

Go deeper on Precivit-E.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Precivit-E.

Explore the full profile